Hepatocellular carcinoma (HCC) is often diagnosed too late, limiting treatment options and survival. The RACOON-MARDER project aims to change that. By combining MRI imaging, clinical data, and AI-based risk stratification, researchers hope to identify high-risk patients earlier and enable personalized, intensified surveillance beyond what traditional ultrasound can offer.
In this interview, Prof. Dr. Timm Denecke (University Hospital Leipzig) explains how AI can make the invisible visible - and why the RACOON infrastructure is key to advancing liver cancer research.
